The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Trends in Breast Cancer by Race and Ethnicity: Update 2006
Open accessAbstract
In this article, the American Cancer Society (ACS) provides estimates of new breast cancer cases and deaths in 2006 and describes trends in incidence, mortality, and survival for female breast cancer in the United States. These estimates are based on incidence data from the National Cancer Institute (NCI) and the North American Association of Central Cancer Registries, which includes state data from NCI and the National Program of Cancer Registries of the Centers for Disease Control and Prevention and mortality data from the National Center for Health Statistics for the most recent years available (1975 to 2002). This article also shows trends in screening mammography. Approximately 212,920 new cases of invasive breast cancer, 61,980 in situ cases, and 40,970 deaths are expected to occur among US women in 2006. As previously reported, breast cancer incidence rates increased rapidly among women of all races from 1980 to 1987, a period when there was increasing uptake of mammography by a growing proportion of US women, and then continued to increase, but at a much slower rate, from 1987 to 2002. Trends in incidence vary by age, race, socioeconomic status, and stage. The continuing increase in incidence (all stages combined) is limited to White women age 50 and older; recent trends are stable for African American women age 50 and older and White women under age 50 years and are decreasing for African American women under age 50 years. Although incidence rates (all races combined) are substantially higher for women age 50 and older (375.0 per 100,000 females) compared with women younger than 50 years (42.5 per 100,000 females), approximately 23% of breast cancers are diagnosed in women younger than 50 years because those women represent 73% of the female population. For women age 35 and younger, age-specific incidence rates are slightly higher among African Americans compared with Whites but then cross over so that Whites have substantially higher incidence at all later ages. Among women of all races and ages, breast cancer mortality rates declined at an average rate of 2.3% per year between 1990 and 2002, a trend that reflects progress in both early detection and treatment. However, death rates in African American women remain 37% higher than in Whites, despite lower incidence rates. Although, in national surveys, approximately 70% of women age 40 years and older report having had a mammogram in the past 2 years, rates vary by race/ethnicity and are markedly lower among women with lower levels of education, without health insurance, and in recent immigrants. Furthermore, a recent study suggests that the true percentage of women having regular mammography is lower than reported in survey data. Encouraging patients age 40 years and older to have annual mammography and clinical breast exam is the single most important step that clinicians can take to reduce suffering and death from breast cancer. Clinicians should also ensure that patients at high risk of breast cancer are identified and offered appropriate referrals and treatment. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,774
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
SUDAAN User's Manual, Release 7.5,
Bieler, G. S., Barnwell, B., & Shah, B. V. (1997) · Cited by 1,273
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,140
Self-citationRacial and Ethnic Disparities in the Receipt of Cancer Treatment
Shavers, V. L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.5.334 · Cited by 950
Kim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 873
Swan, J., Breen, N., Coates, R. J., Rimer, B. K., & Lee, N. C. (2003) · Cancer · doi:10.1002/cncr.11208 · Cited by 767
Race, Socioeconomic Status, and Breast Cancer Treatment and Survival
Bradley, C. J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.490 · Cited by 658
Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome
Chlebowski, R. T., Chen, Z., Anderson, G. L., Rohan, T., Aragaki, A., Lane, D., Dolan, N. C., Paskett, E. D., McTiernan, A., Hubbell, F. A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji064 · Cited by 656
Martin, J. A., Hamilton, B. E., Sutton, P. D., Ventura, S. J., Menacker, F., & Munson, M. L. (2005) · PubMed · Cited by 586
Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000201966.23445.91 · Cited by 386
Factors Associated With Surgical and Radiation Therapy for Early Stage Breast Cancer in Older Women
Ballard-Barbash, R., Potosky, A. L., Harlan, L. C., Nayfield, S. G., & Kessler, L. G. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.716 · Cited by 374
Use of Hormone Replacement Therapy by Postmenopausal Women in the United States
Keating, N. L., Cleary, P. D., Rossi, A. S., Zaslavsky, A. M., & Ayanian, J. Z. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00002 · Cited by 329
Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results
Haas, J. S., Kaplan, C. P., Gerstenberger, E. P., & Kerlikowske, K. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00009 · Cited by 314
Epidemiologic aspects of overweight and obesity in the United States☆
FLEGAL, K. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.08.050 · Cited by 284 · cited 1×
“This decreasing trend in incidence, however, may in part be related to the increasing prevalence of obesity.(20) Although obesity, and more specifically weight gain, is associated with increased risk of breast cancer in postmenopausal women,(21) it is associated with decreased risk among premenopausal women.”
BackgroundImpact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1537 · Cited by 278
Thomas, H. V., Key, T. J., Allen, D. S., Moore, J. W., Dowsett, M., Fentiman, I. S., & Wang, D. Y. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.5.396 · Cited by 246
Brett, K. M., & Madans, J. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009142 · Cited by 241
Feigelson, H. S., Jonas, C. R., Teras, L. R., Thun, M. J., & Calle, E. E. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0301 · Cited by 218
Self-citationReversal of Relation Between Body Mass and Endogenous Estrogen Concentrations With Menopausal Status
Potischman, N., Swanson, C. A., Siiteri, P., & Hoover, R. N. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.756 · Cited by 218
North American Association of Central Cancer Registries
National Cancer Institute (2020) · Definitions · doi:10.32388/cjvuuq · Cited by 161
Wójcik, B. E., Spinks, M. K., & Optenberg, S. A. (1998) · Cancer · Cited by 154
Racial differences in the expression of cell cycle–regulatory proteins in breast carcinoma
Porter, P. L., Lund, M. J., Lin, M. G., Yuan, X., Liff, J. M., Flagg, E. W., Coates, R. J., & Eley, J. W. (2004) · Cancer · doi:10.1002/cncr.20279 · Cited by 137
The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999
Elkin, E. B., Hudis, C. A., Begg, C. B., & Schrag, D. (2005) · Cancer · doi:10.1002/cncr.21285 · Cited by 130
Racial differences in treatment and survival from early‐stage breast carcinoma
Joslyn, S. A. (2002) · Cancer · doi:10.1002/cncr.10827 · Cited by 129
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M. L. S., Lane, D. S., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000093674.44946.d6 · Cited by 119
Jones, B. A., Dailey, A., Calvocoressi, L., Reams, K., Kasl, S. V., Lee, C., & Hsu, H. (2005) · Cancer Causes & Control · doi:10.1007/s10552-005-2905-7 · Cited by 112
Differences in the quality of breast cancer care among vulnerable populations
Haggstrom, D. A., Quale, C., & Smith‐Bindman, R. (2005) · Cancer · doi:10.1002/cncr.21443 · Cited by 112
A New Method of Predicting US and State-Level Cancer Mortality Counts for the Current Calendar Year
Tiwari, R. C., Ghosh, K., Jemal, A., Hachey, M., Ward, E., Thun, M. J., & Feuer, E. J. (2004) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.30 · Cited by 70
Self-citationMagnusson, C., Roddam, A., Pike, M. C., Chilvers, C. E. D., Crossley, B., Hermon, C., McPherson, K., Peto, J., Vessey, M. P., & Beral, V. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602758 · Cited by 58
Talley, L. I., Grizzle, W. E., Waterbor, J. W., Brown, D., Weiss, H. L., & Frost, A. R. (2001) · International Journal of Cancer · doi:10.1002/ijc.10171 · Cited by 55
The relationship between age and incidence of breast cancer population and screening program data
Kessler, L. G. (1992) · Cancer · doi:10.1002/1097-0142(19920401)69:7+<1896::aid-cncr2820691704>3.0.co;2-1 · Cited by 38
Trends in breast cancer mortality rates by region of the United States, 1950?1999
Sturgeon, S. R., Schairer, C., Grauman, D., ghormli, L. K. E., & Devesa, S. S. (2004) · Cancer Causes & Control · doi:10.1007/s10552-004-1092-2 · Cited by 25
Breast Cancer Racial Gap Examined
Vastag, B. (2003) · JAMA · doi:10.1001/jama.290.14.1838 · Cited by 24
Cited by
Epidemiology of basal-like breast cancer
Millikan, R. C., Newman, B., Tse, C.-K., Moorman, P. G., Conway, K., Smith, L. V., Labbok, M. H., Geradts, J., Bensen, J. T., Jackson, S., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9632-6 · Cited by 886
Youlden, D. R., Cramb, S. M., Dunn, N. A. M., Muller, J. M., Pyke, C. M., & Baade, P. D. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.02.007 · Cited by 709
Breast Cancer: Epidemiology and Etiology
Tao, Z., Shi, A., Lu, C., Song, T., Zhang, Z., & Zhao, J. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0459-6 · Cited by 699
The Epidemiology of Renal Cell Carcinoma
Lipworth, L., Tarone, R. E., & McLaughlin, J. K. (2006) · Journal of Urology · doi:10.1016/j.juro.2006.07.130 · Cited by 424
Huo, D., Ikpatt, F., Khramtsov, A., Dangou, J.-M., Nanda, R., Dignam, J., Zhang, B., Grushko, T., Zhang, C., Oluwasola, O., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6873 · Cited by 369
Metadata
- Authors
- Smigal, C., Jemal, A., Ward, E., Cokkinides, V., Smith, R., Howe, H. L., & Thun, M.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2006-05-01
- Volume
- 56
- Issue
- 3
- Pages
- 168-183
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2064052354
- Cited by
- 704
- References
- 36
- FWCI
- 36.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.